Riggs Asset Managment Co. Inc. Iovance Biotherapeutics, Inc. Transaction History
Riggs Asset Managment Co. Inc.
- $359 Million
- Q4 2024
A detailed history of Riggs Asset Managment Co. Inc. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Riggs Asset Managment Co. Inc. holds 374 shares of IOVA stock, worth $1,967. This represents 0.0% of its overall portfolio holdings.
Number of Shares
374
Previous 374
-0.0%
Holding current value
$1,967
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IOVA
# of Institutions
342Shares Held
247MCall Options Held
2.51MPut Options Held
3.5M-
Vanguard Group Inc Valley Forge, PA27.5MShares$145 Million0.0% of portfolio
-
Mhr Fund Management LLC New York, NY24.4MShares$128 Million24.02% of portfolio
-
Perceptive Advisors LLC New York, NY22.1MShares$116 Million5.46% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$112 Million0.0% of portfolio
-
State Street Corp Boston, MA12.2MShares$64.4 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $830M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...